Skip to main content
OpenTrials

Clinical trial condition

ADHD

Explore clinical trials studying ADHD. Study availability and eligibility vary by location and protocol.

395 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

ADHD trial results

Completed

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD

NCT03247517

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Neuropsychiatric Research Center of Orange County Orange, California, United States
  • Indago Research & Health Center, Inc. Hialeah, Florida, United States
  • Clinical Neuroscience Solutions, Inc Jacksonville, Florida, United States
View Trial Details
Completed

Efficacy and Safety of SPD503 in Combination With Psychostimulants

NCT00734578

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Harmonex Neuroscience Research Dothan, Alabama, United States
  • Melmed Center Scottsdale, Arizona, United States
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
View all 61 locations
View Trial Details
Completed

A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

NCT00500149

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Univ. of CA, Irvine Child Development Center Irvine, California, United States
  • Shire Clinical Research Site Wildomar, California, United States
  • Vince and Associates Clinical Research Overland Park, Kansas, United States
View Trial Details
Completed

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

NCT00367835

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • HOPE Research Institute Phoenix, Arizona, United States
  • Valley Clinical Research El Centro, California, United States
  • Peninsula Research Associates Inc Rolling Hills Estates, California, United States
  • Sarkis Clinical Trials Gainesville, Florida, United States
View all 34 locations
View Trial Details
Completed

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

NCT00763971

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • ZiekenhuisNetwerk Antwerpen, Commandant Weynsstraat 165, Campus Hoge Beuken Hoboken, Antwerp, Belgium
  • Universitair Ziekenhuis Gent, Kinder-en Jeugdpsychiatrie, De Pintelaan 185 Ghent, East Flanders, Belgium
  • Afdeling Psychiatrie, UZ Herestraat 49, Bus 07003 Leuven, Belgium
  • Hospital Archet 2 Nice, Cedex 03, France
View all 49 locations
View Trial Details
Completed

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

NCT00764868

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Penninsula Research Associates, Inc. Rolling Hills Estates, California, United States
  • Psychiatric Centers at San Diego (PCSD-Feighner Research Institute) San Diego, California, United States
View all 45 locations
View Trial Details
Completed

Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT00697515

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • University of CA, Irvine Child Development Center Irvine, California, United States
  • Vince & Associates Clinical Research Overland Park, Kansas, United States
  • Center for Psychiatry & Behavioral Medicine, Inc Las Vegas, Nevada, United States
View Trial Details
Completed

Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17

NCT00784654

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Peninsula Research Associates, Inc. Rolling Hills Estates, California, United States
  • Miami Research Associates South Miami, Florida, United States
  • Vince and Associates Clinical Research Overland Park, Kansas, United States
  • CNS Healthcare Memphis, Tennessee, United States
View all 51 locations
View Trial Details

Related conditions